475 related articles for article (PubMed ID: 28889265)
1. Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.
Bryan MR; Bowman AB
Adv Neurobiol; 2017; 18():113-142. PubMed ID: 28889265
[TBL] [Abstract][Full Text] [Related]
2. Acute manganese treatment restores defective autophagic cargo loading in Huntington's disease cell lines.
Bryan MR; O'Brien MT; Nordham KD; Rose DIR; Foshage AM; Joshi P; Nitin R; Uhouse MA; Di Pardo A; Zhang Z; Maglione V; Aschner M; Bowman AB
Hum Mol Genet; 2019 Nov; 28(22):3825-3841. PubMed ID: 31600787
[TBL] [Abstract][Full Text] [Related]
3. Manganese Acts upon Insulin/IGF Receptors to Phosphorylate AKT and Increase Glucose Uptake in Huntington's Disease Cells.
Bryan MR; Nordham KD; Rose DIR; O'Brien MT; Joshi P; Foshage AM; Gonçalves FM; Nitin R; Uhouse MA; Aschner M; Bowman AB
Mol Neurobiol; 2020 Mar; 57(3):1570-1593. PubMed ID: 31797328
[TBL] [Abstract][Full Text] [Related]
4. Altered manganese homeostasis and manganese toxicity in a Huntington's disease striatal cell model are not explained by defects in the iron transport system.
Williams BB; Kwakye GF; Wegrzynowicz M; Li D; Aschner M; Erikson KM; Bowman AB
Toxicol Sci; 2010 Sep; 117(1):169-79. PubMed ID: 20547568
[TBL] [Abstract][Full Text] [Related]
5. Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
Naia L; Ferreira IL; Cunha-Oliveira T; Duarte AI; Ribeiro M; Rosenstock TR; Laço MN; Ribeiro MJ; Oliveira CR; Saudou F; Humbert S; Rego AC
Mol Neurobiol; 2015 Feb; 51(1):331-48. PubMed ID: 24841383
[TBL] [Abstract][Full Text] [Related]
6. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.
Ribeiro M; Rosenstock TR; Oliveira AM; Oliveira CR; Rego AC
Free Radic Biol Med; 2014 Sep; 74():129-44. PubMed ID: 24992836
[TBL] [Abstract][Full Text] [Related]
7. A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.
Tidball AM; Bryan MR; Uhouse MA; Kumar KK; Aboud AA; Feist JE; Ess KC; Neely MD; Aschner M; Bowman AB
Hum Mol Genet; 2015 Apr; 24(7):1929-44. PubMed ID: 25489053
[TBL] [Abstract][Full Text] [Related]
8. Untargeted metabolic profiling identifies interactions between Huntington's disease and neuronal manganese status.
Kumar KK; Goodwin CR; Uhouse MA; Bornhorst J; Schwerdtle T; Aschner M; McLean JA; Bowman AB
Metallomics; 2015 Feb; 7(2):363-70. PubMed ID: 25599126
[TBL] [Abstract][Full Text] [Related]
9. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
[TBL] [Abstract][Full Text] [Related]
10. Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model.
Bichell TJV; Wegrzynowicz M; Tipps KG; Bradley EM; Uhouse MA; Bryan M; Horning K; Fisher N; Dudek K; Halbesma T; Umashanker P; Stubbs AD; Holt HK; Kwakye GF; Tidball AM; Colbran RJ; Aschner M; Neely MD; Di Pardo A; Maglione V; Osmand A; Bowman AB
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1596-1604. PubMed ID: 28213125
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
12. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
[TBL] [Abstract][Full Text] [Related]
13. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
Olesen MA; Villavicencio-Tejo F; Quintanilla RA
Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
[TBL] [Abstract][Full Text] [Related]
14. Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin.
Naia L; Ribeiro M; Rodrigues J; Duarte AI; Lopes C; Rosenstock TR; Hayden MR; Rego AC
Neuropeptides; 2016 Aug; 58():73-81. PubMed ID: 26876526
[TBL] [Abstract][Full Text] [Related]
15. Huntington's disease associated resistance to Mn neurotoxicity is neurodevelopmental stage and neuronal lineage dependent.
Joshi P; Bodnya C; Ilieva I; Neely MD; Aschner M; Bowman AB
Neurotoxicology; 2019 Dec; 75():148-157. PubMed ID: 31545971
[TBL] [Abstract][Full Text] [Related]
16. Compromised IGF signaling causes caspase-6 activation in Huntington disease.
Skotte NH; Pouladi MA; Ehrnhoefer DE; Huynh K; Qiu X; Nielsen SMB; Nielsen TT; Nørremølle A; Hayden MR
Exp Neurol; 2020 Oct; 332():113396. PubMed ID: 32622701
[TBL] [Abstract][Full Text] [Related]
17. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
Aladdin A; Király R; Boto P; Regdon Z; Tar K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
[TBL] [Abstract][Full Text] [Related]
18. Multiple phenotypes in Huntington disease mouse neural stem cells.
Ritch JJ; Valencia A; Alexander J; Sapp E; Gatune L; Sangrey GR; Sinha S; Scherber CM; Zeitlin S; Sadri-Vakili G; Irimia D; Difiglia M; Kegel KB
Mol Cell Neurosci; 2012 May; 50(1):70-81. PubMed ID: 22508027
[TBL] [Abstract][Full Text] [Related]
19. Restoration of c-Src/Fyn Proteins Rescues Mitochondrial Dysfunction in Huntington's Disease.
Fão L; Coelho P; Duarte L; Vilaça R; Hayden MR; Mota SI; Rego AC
Antioxid Redox Signal; 2023 Jan; 38(1-3):95-114. PubMed ID: 35651273
[No Abstract] [Full Text] [Related]
20. Mn(II) Quinoline Complex (4QMn) Restores Proteostasis and Reduces Toxicity in Experimental Models of Huntington's Disease.
Merino M; Sequedo MD; Sánchez-Sánchez AV; Clares MP; García-España E; Vázquez-Manrique RP; Mullor JL
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
